MarkRussellLingMD

Dermatology • Newnan, GA

Dermatologic Surgery

President, MedaPhase, Inc.; Managing Partner, Newnan Dermatology

Join to view full profile

Dr. Ling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ling's full profile

Already have an account?

Office
710 Newnan Crossing Bypass
Newnan, GA 30263
Phone+1 770-251-5111

Fax+1 770-254-8680

Education & Training

University of Pennsylvania Health SystemResidency, Dermatology, 1987 - 1990
Duke University School of MedicineClass of 1984

Certifications & Licensure

GA State Medical License 1991 - 2025
PA State Medical License 1985 - 2004
NY State Medical License 1990 - 1992
NJ State Medical License 1988 - 1991
American Board of Dermatology Dermatology
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2013
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2010 Aug 01
Completed
Phase 2
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 May 01
Completed
Phase 3
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) Start of enrollment: 2016 Jan 21
Completed
Phase 3

Publications & Presentations

PubMed

8 citations
BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
Andrew F Alexis, Del Rosso Jq, Desai, Jeanine Downie, Zoe Diana Draelos
The Journal of Clinical and Aesthetic Dermatology. 2018-11-01
29 citations
Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in ...
Angela Yen Moore, Mark Ling, Alicia D. Bucko, Vasant Manna, Marie-Jose Rueda
Journal of Drugs in Dermatology. 2015-06-01
15 citations
A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
James J. Leyden, Suzanne Bruce, Chai Sue Lee, Mark Ling, Pranav Sheth
Journal of Drugs in Dermatology. 2013-06-01

Press Mentions

Avail Dermatology Joins Epiphany DermatologyOctober 1st, 2021
Dr. Wallace Nozile Heads New Avail Dermatology Location in StockbridgeFebruary 16th, 2021
Avail Dermatology Marks Growth with New Name, Additional LocationNovember 13th, 2017

Professional Memberships

American Academy of Dermatology - AAD
Fellow